R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2023-07-28
- Last Posted Date
- 2024-05-21
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Registration Number
- NCT05966233
- Locations
- ๐ฎ๐น
ASST Grande Ospedale Metropolitano Niguarda, SC Ematologia, Milano, Italy
๐ฎ๐นP.O. Spirito Santo di Pescara, UOS Dipartimentale - Centro di diagnosi e Terapia dei linfomi, Pescara, Italy
๐ฎ๐นA.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia, Alessandria, Italy
Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors
- Conditions
- Interventions
- First Posted Date
- 2023-07-06
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 552
- Registration Number
- NCT05934084
- Locations
- ๐ฎ๐น
IEO Istitito Europeo di Oncologia - Divisione Ematoncologia, Milano, Italy
๐ฎ๐นOspedale Maggiore Policlinico - Fondazione IRCCS Ca Granda - Ematologia, Milano, Italy
๐ฎ๐นIstituto Tumori Bari Giovanni Paolo II, U.O. di Ematologia e Terapia Cellulare, Bari, Italy
Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi
- Conditions
- Interventions
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 190
- Registration Number
- NCT05929222
- Locations
- ๐ฎ๐น
Istituto Tumori Bari Giovanni Paolo II, U.O. di Ematologia e Terapia Cellulare, Bari, Italy
๐ฎ๐นAzienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia, U.O. Ematologia, Brescia, Italy
๐ฎ๐นAzienda Ospedaliero Universitaria Pisana, U.O. Ematologia, Pisa, Italy
Primary Cardiac Lymphoma: Italian Multicenter Experience
- Conditions
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 43
- Registration Number
- NCT05819528
- Locations
- ๐ฎ๐น
AOU di Sassari - Ematologia, Sassari, SS, Italy
๐ฎ๐นAzienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - SC Ematologia, Trieste, TS, Italy
๐ฎ๐นOspedale Dell'angelo - U.O. Ematologia, Mestre, Venezia, Italy
Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 654
- Registration Number
- NCT05816850
- Locations
- ๐ฎ๐น
A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia, Alessandria, Italy
๐ฎ๐นAOU Maggiore della Caritร di Novara, SCDU Ematologia, Novara, Italy
๐ฎ๐นA.O. Ospedali Riuniti Villa Sofia-Cervello, Divisione di Ematologia, Palermo, Italy
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
- Conditions
- First Posted Date
- 2022-09-01
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 150
- Registration Number
- NCT05524298
- Locations
- ๐ฎ๐น
S.C. Ematologia - A.O. SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
๐ฎ๐นClinica di Ematologia - A.O.U. Ospedali Riuniti, Ancona, Italy
๐ฎ๐นDivisione di Oncologia e dei Tumori immuno-correlati - IRCCS Centro di Riferimento Oncologico di Aviano, Aviano, Italy
Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients
- Conditions
- Interventions
- First Posted Date
- 2022-03-29
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 122
- Registration Number
- NCT05300282
- Locations
- ๐ฎ๐น
Ematologia - ASST Spedali Civili di Brescia, Brescia, Italy
๐ฎ๐นEmatologia - Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
๐ฎ๐นSC Ematologia - ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients.
- Conditions
- Interventions
- First Posted Date
- 2022-02-22
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 49
- Registration Number
- NCT05249959
- Locations
- ๐ฎ๐น
S.C. di Ematologia - A.O. S. Croce e Carle, Cuneo, Italy
๐ฎ๐นDivisione di Ematologia - A.O. Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
๐ฎ๐นDivisione di Ematologia - IRCCS Policlinico S. Matteo di Pavia, Pavia, Italy
Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study
- Conditions
- First Posted Date
- 2021-12-17
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 633
- Registration Number
- NCT05162170
- Locations
- ๐ฎ๐น
Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico, Avellino, Italy
๐ฎ๐นU.F. Oncoematologia, IOM (Istituto Oncologico del Mediterraneo), Viagrande, Catania, Italy
๐ฎ๐นSC Ematologia, A.O. SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
Circulating Tumor DNA Genotyping for Biological Monitoring of Patients Treated in the FIL-Rouge Clinical Trial
- Conditions
- First Posted Date
- 2021-10-04
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 100
- Registration Number
- NCT05066555
- Locations
- ๐ฎ๐น
Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico, Avellino, Italy
๐ฎ๐นIRCCS Istituto Tumori Giovanni Paolo II - U.O.C Ematologia, Bari, Italy
๐ฎ๐นASST Spedali Civili di Brescia - Ematologia, Brescia, Italy